Key facts
- This page summarizes Benoit Chardon's Form 3 filing for ALLURION TECHNOLOGIES, INC. (ALUR).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 01 Aug 2023, 20:55.
Benoit Chardon - 01 Aug 2023 Form 3 Insider Report for ALLURION TECHNOLOGIES, INC. (ALUR)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- ALUR
- Reported as of
- 01 Aug 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 01 Aug 2023, 20:55:08 UTC
- Next SEC filing
- 14 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Ausrotas, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Benoit Chardon filed Form 3 for ALLURION TECHNOLOGIES, INC. (ALUR) on 01 Aug 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALUR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,644
- Date
- 01 Aug 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALUR
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 97,799
- Exercise price
- $1.13
- Footnotes
- F1
ALUR
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 24,449
- Exercise price
- $1.17
- Footnotes
- F2
ALUR
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 29,339
- Exercise price
- $0.9500
- Footnotes
- F3
ALUR
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 24,449
- Exercise price
- $1.88
- Footnotes
- F4
ALUR
holding
Derivative
Contingency Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 48,133
- Exercise price
- Footnotes
- F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
This option is fully vested.
Footnote F2
This option shall vest and become exercisable in monthly installments over a period of 48 months from January 1, 2020, subject to the Reporting Person's continued service on each such vesting date.
Footnote F3
25% of the shares underlying this option vested on July 1, 2021, and the remainder vests in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Footnote F4
25% of the shares underlying this option vested on January 1, 2023, and the remainder vests in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Footnote F5
Subject to the terms and conditions pursuant to that certain Business Combination Agreement ("BCA") dated as of February 9, 2023, as amended on May 2, 2023, by and among Compute Health Acquisition Corp., Compute Health Corp., Compute Health LLC, the Issuer (fka Allurion Technologies Holdings, Inc.), and Allurion Technologies, Inc. ("Private Allurion"), the contingent right to receive shares of Common Stock ("Contingency Shares"), was issued as follows: one-half of the Contingency Shares, in the aggregate, if, from the period beginning on the date on which the Issuer's registration statement on Form S-1 with respect to the resale of any Common Stock issued pursuant to the PIPE Financing is declared effective by the SEC until the date which is five calendar years after the Closing Date ("Earnout Period"),
Footnote F6
(Continued from footnote 5) the VWAP is greater than or equal to $15.00 over any 20 trading days within any consecutive 30 trading day period ("First Share Target"); and one-half of the Contingency Shares, in the aggregate, if, during the Earnout Period, the VWAP is greater than or equal to $20.00 over any 20 trading days within any consecutive 30 trading day period ("Second Share Target").
SEC remarks
Exhibit 24 - Power of Attorney